18 May 2013
Keywords: takeda, develop, synsorb, coli, drug, canadian, company
Article | 23 December 1996
Canadian company Synsorb Biotech has granted exclusive rights for one of
its key products, Synsorb Pk for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com